POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED powder, for solution
POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES WITH LEMO Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

polyethylene glycol 3350 and electrolytes - unflavored powder, for solution polyethylene glycol 3350 and electrolytes with lemo

strides pharma science limited - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium sulfate anhydrous - unii:36kcs0r750), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chlorate (unii: h35ks68ee7) (potassium cation - unii:295o53k152, chlorate ion - unii:08z8093742) - polyethylene glycol 3350 and electrolytes for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults polyethylene glycol 3350 and electrolytes for oral solution, is contraindicated in the following conditions: -   gastrointestinal (gi) obstruction [see warnings and precautions (5.6)] -   bowel perforation [see warnings and precautions (5.6)] -   toxic colitis or toxic megacolon -   gastric retention -   ileus -   hypersensitivity to any component of polyethylene glycol 3350 and electrolytes for oral solution [see warnings and precautions (5.8)] animal reproduction studies have not been conducted with polyethylene glycol 3350 and electrolytes for oral solution. it is also not known whether polyethylene glycol 3350 and electrolytes for oral solution, can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. polyethylene glycol 3350 and electrolytes for oral solution, should be given to a pregnant woman only if clearl

POLYETHYLENE GLYCOL 3350 powder, for solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

polyethylene glycol 3350 powder, for solution

atlantic biologicals corps - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - for the treatment of occasional constipation. this product should be used for 2 weeks or less or as directed by a physician. polyethylene glycol 3350 nf is contraindicated in patients with known or suspected bowel obstruction and patients known to be allergic to polyethylene glycol.

PEG 3350- polyethylene glycol 3350 powder, for solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

peg 3350- polyethylene glycol 3350 powder, for solution

major pharmaceuticals - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - laxative - relieves occasional constipation (irregularity) - generally produces a bowel movement in 1 to 3 days

PEG 3350- polyethylene glycol 3350 powder, for solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

peg 3350- polyethylene glycol 3350 powder, for solution

cardinal health - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - purpose osmotic laxative original prescription strength compare to miralax® -relieves occasional constipation (irregularity) -softens stool stop use and ask a doctor if - you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse.these may be signs of a serious condition. - you get diarrhea - you need to use a laxative for longer than 1 week - side effects occur use -relieves occasional constipation (irregularity) -generally produces a bowel movement in 1 to 3 days distributed by: major pharmaceuticals 17177 n laurel park drive, suite 233 livonia, mi 48152 usa distributed by: cardinal health dublin, oh 43017 l50719800519

EZ2GO PEG 3350- polyethylene glycol 3350 powder Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

ez2go peg 3350- polyethylene glycol 3350 powder

valley medical products,llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - purpose osmotic laxative stop use and ask a doctor if - you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse.these may be sogns of a serious condition. - you get diarrhea - you need to use a laxative for longer than 1 week - side effects occur use -relieves occasional constipation (irregularity) -generally produces a bowel movement in 1 to 3 days

MOVIPREP- polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid kit Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

moviprep- polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid kit

physicians total care, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium cation - unii:lyr4m0nh37), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 100 g in 1 l - moviprep® is indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. moviprep is contraindicated in patients who have had a severe hypersensitivity reaction to any of its components. pregnancy category c. animal reproduction studies have not been performed with moviprep.  it is also not known if moviprep can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. moviprep should be given to a pregnant woman only if clearly needed. because many drugs are excreted in human milk, caution should be exercised when moviprep is administered to a nursing woman. the safety and effectiveness of moviprep in pediatric patients has not been established. of the 413 patients in clinical studies receiving moviprep, 91 (22%) patients were aged 65 or older, while 25 (6%) patients were over 75 years of age.  no overall differences in safety or effectiveness were observed between geriatric patients and younger patients, and other repo

COLYTE WITH FLAVOR PACKS polyethylene glycol 3350 sodium chloride potassium bicarbonate and sulfate powder for solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

colyte with flavor packs polyethylene glycol 3350 sodium chloride potassium bicarbonate and sulfate powder for solution

alaven pharmaceutical llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 240 g in 4 l

COLYTE polyethylene glycol 3350 sodium chloride potassium bicarbonate and sulfate anhydrous powder for solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

colyte polyethylene glycol 3350 sodium chloride potassium bicarbonate and sulfate anhydrous powder for solution

alaven pharmaceutical llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 227.1 g in 3.785 l

MIRALAX- polyethylene glycol 3350 powder, for solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

miralax- polyethylene glycol 3350 powder, for solution

bayer healthcare llc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative osmotic laxative - relieves occasional constipation (irregularity) - generally produces a bowel movement in 1 to 3 days

DG HEALTH CLEARLAX- polyethylene glycol 3350 powder, for solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dg health clearlax- polyethylene glycol 3350 powder, for solution

dolgencorp, llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative